Introduction

!
Diabetes mellitus (DM), the worldʼs most common metabolic disorder, results from a defect in insulin secretion, insulin action, or both [1] . It is projected that the global prevalence of diabetes is escalating. At least 250 million individuals worldwide suffer from diabetes, and this number will double by 2030. Increases in complications will undoubtedly follow increasing pervasiveness of diabetes [2] . The regional prevalence of diabetes in MENA (Middle Eastern and North Africa) countries is 7.7 % [3] . Standing at 10.1 %, Jordan has the ninth highest incidence of diabetes. Several national surveys indicated that the prevalence of type 2 diabetes and impaired fasting glycemia is in an unprecedented increase with an epidemiological transition in Jordan [4] [5] [6] . More than 80% of diabetes deaths occur in low-and middle-income countries. Endocrine, nutritional, and metabolic diseases represent 7.9 % of deaths in Jordan [7] [8] . Located in the Middle East, Jordan covers 92 300 km 2 with high geographical and ecological diversity. Its varied topography and climate result in the junction of four biogeographical regions Fig. 1S , and these crossroads engender the country with substantial biodiversity that is at large understudied or, even worse, left unexplored [9] . The Mediterranean region provides the vast majority of the recorded 2500 wild plant species, including medicinal, poisonous, edible, and ornamental ones. There are more than 140 wild edible plants listed such as Rumex crispus, R. vesicarius, Gundelia tournefortii, Origanum syriacum, Foeniculum vulgare, and Chicorium pumilum. Some of these edible and culinary plants are used by local communities for generations for their medicinal value [10] [11] [12] . In Jordan, where traditional medicine plays a partial role in imparting the primary health care, vegetables, culinary herbs, and medicinal plants are among the main choices in the management of diabetes [13, 14] . However, it is officially neither integrated in the health care system nor recognized in national policies of the country. The objective of this mini review is to underline the ethnopharmacological practices related to 30 selected ethnobotanicals with claimed antidiabetic properties in light of their comprehensive scientific evaluation.
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Diabetes mellitus is the most common metabolic disorder affecting millions worldwide. It is recognized as a global major health problem. As alternatives to the available orthodox medicines, plants are considered a potential source for the treatment of diabetes within traditional ethnomedicine practices. In the Jordanian traditional medicine a significant selection of ethnobotanicals is promoted for their antidiabetic activity. Literature surveys demonstrate the benefit of several ethnobotanicals as antidiabetic agents evaluated in in vitro and in vivo systems in the form of their crude extracts and/or isolated pure compounds with varying degrees of hypoglycemic or antihyperglycemic bioactivities. This mini review discusses the preparatory forms in which these plants are consumed, their reported phytoconstituents, and the results of their reported antidiabetic bioactivity. Locally, one of the common practices is to assign certain species of a given genus a single common Arabic name with the expectation that all of them will perform ethnopharmacologically equally. This unjustifiable practice is based on species availability. In application, and despite scientific invalidity, the three Artemisia, both Cichorium spp., and the two Crataegus species have been the subject of such inappropriate convenience of designation. Plants compiled in l " Table 1 ). Several studies indicated the hypoglycemic benefits of flavonoids such as hesperidin, quercetin, luteolin, naringenin, and rutin in STZ-diabetic rats [44] [45] [46] [47] [48] . Leaf decoctions of common fruit trees -C. siliqua, J. regia, and M. nigra -and the peels of C. sinensis are praised throughout the country for their antidiabetic activities. These substantial efficacies have been clearly verified. Moreover, the antidiabetic efficiency of C. siliqua leaf extracts has been confirmed in type 2 diabetic patients (l " Table 1 ).
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Conclusion
!
Based on hundreds of years of belief and observation, a marked number of plant species are used by the inhabitants of Jordan for the treatment of diabetes. The traditional knowledge of plants Antidiabetic effect sin STZ-diabetic rats via acting as an insulinmimetic reversing the changes in the enzyme activities of cytochrome P-450 (2E1, 2B, and 2C) on androst-4-ene-3,17-dione me-
Estrogenic flavonoids [62] . Jaceosidine, eupafolin, luteolin, quercetin, apigenine, aesculetin, esculetin-6-methylether, and scopoletin [63] . Yomogin [64] . Dicaffeoylquinic acids [65] . Sesquiterpene lactones and a novel aromatic compound [66] . Trans-thujone, cis-thujone, chrysanthenyl acetate, 1,8-cineole, sabinene, β-pinene, artemisia ketone, caryophyllene, oxygenated monoterpenes, sesquiterpenes [67] . Flavonoid aglycon: quercetin 3,7,3′-trimethyl ether [68] None 4 Asteraceae Cichorium intybus L.
(decoction of flowers, roots [69] )
Dietary fructans [70] . Anthocyanins [71] . Sesquiterpene lactones of guaiane and germacrane type. Lactucopicrin, 8-desoxylactucin, and three sesquiterpene lactone glycosides: crepidiaside B, sonchuside A, and ixerisoside D [72] . Lactucin and lactucopicrin: sesquiterpene lactones [73] . Quercetin, kaempferol, luteolin, apigenin, crysoeriol and caffeoyl derivatives, polyphenols [74] . Flavonoids [75] . A guaianolide sesquiterpene glycoside, cichotyboside [76] . Tannins, chlorogenic acid along with caffeic acid derivatives [77] Antihyperglycemic effect in alloxan-induced diabetes mice [78] and clinically proven reduction on diabetes risk [79] , which can be explained by a reduction in intestinal absorption of glucose [80] . Significant increases in catalytic concentration of glutathione S-transferases in the liver of diabetic NOD mice [81] . Its dietary inulin-type fructans promote secretion of endogenous gastrointestinal peptides involved in appetite regulation [82] and via reduction in the hepatic Glc-6-pase activity thus decreasing hepatic glucose production, with no possibility of inducing insulin secretion from pancreatic beta-cells [83] , also through adipogenesis inhibition and PPARgamma upregulation, inhibition of protein tyrosine phosphatase 1B and regulation of insulin signalling markers [77, 84] . α-Glucosidase inhibition [85] . Insulin-sensitizing and insulin-secreting principles [86] . Neuroprotection by stimulating AChE activity in brains of alloxan diabetic rats [87] Polyphenols and flavonoids: ferulic acid; the chief derivative of hydroxycinnamic acid, rutin, and isorhamnetin derivatives [91] . Betacyanins and betaxanthins [92] . Kaempferol and isorhamnetin glycosides (glucoside and rhamnoside) [93] Hypoglycemic effects [94] 7 Capparaceae Capparis spinosa L.
(decoction of flowers, fruits [69] )
Saccharides and glycosides, flavonoids, alkaloids, terpenoids and volatile oils, fatty acids and steroids [95] . Antioxidative capparoside (4-hydroxy-5-methylfuran-3-carboxylic acid, 1) [96] . Phenolics: rutin, tocopherols, carotenoids, and vitamin C [97] . Flavonoids, indoles, and phenolic acids [98] Potent antihyperglycemic activity in STZ rats without affecting basal plasma insulin concentrations [99] . Hypoglycemic activity [95] Tertiary and quaternary alkaloids, glycoside and saponin components [101] . Phenolics and flavonoids [102] Hypoglycemic and antihyperglycemic effects in normal and alloxan diabetic rabbits [101] and STZ diabetic rats [103] by partly preserving or restoring pancreatic beta-cell mass [104] and insulinotropic effect [105] . Clinical beneficial effect on improving the glycemic profile without severe adverse effects in type 2 diabetic patients [106] continued next page Flavonoids: mainly myricetin [108] . Phenolics: mainly gallotannins and proanthocyanidins, tannins, flavonol-glycosides, and traces of isoflavonoids [109] [110] [111] [112] . Tannins [113] Significantly decreased the glucose response to and glycemic index of fibers-enriched food in type 2 diabetic subjects. It also tended to decrease their insulinemic response and insulinemic index [114] . Increases total and acylated plasma ghrelin accompanied by enhanced lipid metabolism, thus suggesting higher lipid utilization and suppressed lipolysis, without affecting fasting concentrations of glucose, TAG, total ghrelin, NEFA, insulin, and leptin [115] 10 Graminae Avena sativa L.
(infusion of seeds [69] )
Beta-glucan, minerals, B complex vitamins, protein, fat, minerals [116] . Avenanthramide [117] Improving glycemic, insulinemic, and lipidemic responses [118] .
Oatmeal test seemed to be a good, noninvasive screening test in diabetic gastropathy in type 1 diabetes, but has no diagnostic value in type 2 diabetes [119] . Depression of the glycemic index by high levels of beta-glucan fiber making it a useful functional food component for reducing postprandial glycemia [120, 121] . Significantly improved whole-body insulin sensitivity [122, 123] induced changes of postprandial peptide YY and ghrelin responses [124] and increased postprandial cholecystokinin levels [125] . Dihydroavenanthramide D protects pancreatic beta-cells from cytokine and STZ toxicity [117] Monoterpene glucosides [140] , oxygenated monoterpenes and sesquiterpenes [141] . Polar phenolic analytes; hydroxyl-benzoates, hydroxylcinnamates, and flavonoids [142] . Carvacrol, thymol, and thymoquinone [143] . Rosmarinic, oleanolic, and ursolic acids [144] . Cinnamoyl, p-coumaroyl, feruloyl, caffeoyl aloesin [159] . Phenols, flavonoids, ascorbic acid, β-carotene and α-tocopherol [160] . Mannose polymers with some glucose and other sugars; mainly acemannan, glycoproteins, enzymes, amino acids, vitamins, and minerals [161] . Anthraquinones: aloesin, aloe-emodin, and barbaloin, N-terminal octapeptide derived from verectin [162] and triglucosylated naphthalene glycoside [163] Hypoglycemic or antidiabetic effects [164] thereby indicated for the treatment of diabetes and dyslipidemia [165] continued next page Anthocyanins [166] . Olcancolic acid, apingenin, cyclocommunol, morusin, cyclomorusin, kuwanon C, daucosterol [167] . Essential minerals, nutritive components, total phenols, and alkaloid contents [168] . A new 2-arylbenzofuran derivative, mornigrol D, G, and H along with norartocarpetin, dihydrokaempferol, albanin A, albanin E, moracin M, and albafuran C [169] Antihyperglycemic propensity via significant increases in catalytic concentration of glutathione S-transferases in the liver of diabetic NOD mice [170, 171] 
acid, ellagic acid, and gallic acid [174] ) and cypellocarpa C [175] In vitro stepwise enhancement of insulin secretion from the clonal pancreatic beta-cell line (BRIN-BD11) and enhancement of 2-deoxyglucose transport, glucose oxidation, and incorporation of glucose into glycogen in mouse abdominal muscle [176, 177] . Antihyperglycemic action not exerted via the stimulation of insulin secretion but via enhancement of peripheral glucose uptake, exerting an antioxidative activity demonstrated by the increase of catalase, superoxide-dismutase, and gluthatione-peroxidase activities in the liver and kidney, and a lowering of lipids peroxidation level in these organs [178] . Significantly improved the hyperglycemia, polydipsia, polyphagia, and also compensated weight loss of diabetic rats, in addition to treatment of candidiasis in normal and diabetic rats [179] . Ursolic acid [181] . Polysaccharides, lipids, caffeic acid derivatives, iridoid glycosides, terpenoids, alkaloids [182] . Phenolic glycoside [183] . Antioxidative flavonoids [184] Significant antihyperglycemic effect in experimental diabetic rats [185, 186] 20 Plantaginaceae P. ovata Forsk. (decoction of seeds [69] )
Neutral arabinoxylan [187] . Phytosterols; β-sitosterol and stigmasterol [188] . Saponin [189] Fasting blood glucose and HbA1c showed a significant reduction, whereas HDL-Cholesterol increased significantly. LDL/HDL ratio was significantly decreased in diabetic outpatients [190] 
21
Portulacaceae Portulaca oleraceae L.
(decoction of herb [69, 107] )
β-sitosterol, β-sitosterol-glucoside, N,N′-dicyclohexylurea, and allantoin [191] . Portulene; a diterpene [192] . Phenolic alkaloids; oleracein A, oleracein B, and oleracein E [193] . Betacyanins [194] Moderate antidiabetic activity via potent antioxidant potential in STZ-diabetic rats [195] 22 Rosaceae Crataegus aronia L. Bosc. ex DC (decoction of flowers, fruits [196] )
Phenolics and flavonoids [197] Hypoglycemic and antiperoxidative bioactivities in experimental diabetic rats [198] Hydroxycinnamates and polymethoxylated flavones in citrus peel molasses [200, 201] . Flavonoids: eriocitrin and hesperidin [202] . Phenolics and flavonoids [203] . Naringenin [204] . Limonoids: nomilin and limonin [205] . Ascorbic acid [206] . Flavonoid dimethylnobiletin [207] Antioxidative in diabetic rats [202, 203] . Increases glucose uptake by skeletal muscle cells in an AMPK-dependent manner [204] . Cardiovascular friendly [208] . Anti-atherogenic bioactivities; inhibiting monocyte-to-macrophage differentiation and foam cell formation as well as hypolipidemic activity via enhancing LDL receptor gene expression and activity and decreasing acyl CoA: diacylglycerol acyltransferase 2 expression in HepG2 liver cells [207] Alkaloids, flavonoids, cardiac glycosides, tannins, and saponin [200] . Furanocoumarins [210] . Naringenin [204] and nootkatone [211] . 4′-geranyloxyferulic acid [212] . Limonoids: nomilin and limonin [205] Hypoglycemic and hypolipidemic effects in normal and alloxan diabetic rats [209, 213] . Improving glycemic control in nondiabetic rats [214] . Increasing glucose uptake by skeletal muscle cells in an AMPK-dependent manner [204] , thus significantly reducing highfat and high-sucrose diet-induced body weight gain, abdominal fat accumulation, and the development of hyperglycemia, hyperinsulinemia, and hyperleptinemia in C57BL/6J mice [211] continued next page shown in relation to their medicinal use reflects a striking diversity of species and uses, as well as their importance in popular plant therapy. Pharmacologic and therapeutic evaluation of the selected plants in this review explicitly substantiates the ethnopharmacological practices in Jordan. These traditions could pave the way for future phytochemical and pharmacological studies, thereby contributing to alternative therapeutic strategies to available drugs with undesirable adverse effects or those lacking in satisfactory efficacy or safety.
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In Table 1S of the Supporting information, the up-to-date reported pharmacological activities of the selected medicinal plants with claimed antidiabetic propensities are discussed. On the other hand, l " Table 1 includes the reported antidiabetic efficacy and/or action mechanism of the same selection of medicinal plants.
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The authors declare none. Phenolics: chlorogenic acid, luteolin, myricetin, naringenin, p-coumaric acid, and quercetin; and flavonoids -mainly hesperidine [215, 216] . Flavanones [217] . Cyclic monoterpene, DL-limonene [218] . Ascorbic acid [219] Maximum glucose lowering and antiperoxidative activities in alloxan diabetic mice [220] . Antithyroidal, hypoglycemic, and insulin stimulatory properties, suggesting its potential to ameliorate both hyperthyroidism and diabetes mellitus [221] . Significant decrease in fasting glucose levels in the overweight treatment group of osteoarthritis patients [222] . Lack of α-glucosidase inhibitory effects [223] . Selective inhibition of aldose reductase [224] and reduction of advanced glycation end products and H 2 O 2 induced oxidative stress in human adipocytes [225] Polyacetylenes [228] . [229] . Monoterpenoids, glycosides, monoterpenoid glucoside sulfates, and aromatic compound glycosides [230] Antihyperglycemic, insulin-releasing, and insulin-like activity [231, 232] 29
Monoterpenoid glucosides [233] . Sesquiterpene lactone glucosides and alkyl glycosides [234] . A flavonoid glycoside; 3′,5-dihydroxyflavone 7-O-β-D-galacturonide 4′-O-β-D-glucopyranoside [235] . Cuminlaldehyde, γ-terpinene, o-cymene, β-pinene, 2-caren-10-al, trans-carveol, and myrtenal [236] Antihyperglycemic effect [237] comparable to glibenclamide and inhibition of advanced glycation end products formation in STZdiabetic rats [238] . Aldose reductase and α-glucosidase inhibition [239] 30 Umbelliferae Eryngium creticum Lam. (decoction of aerial parts [100] )
A unique n-propyl sesquiterpene [240] Hypoglycemic effects [241] in rat models. Favorable acute antihyperglycemic trend in starch-fed rats despite the lack of in vitro inhibitory activity of α-amylase and α-glucosidase [23] 11 Al Eisawi DM. 
